Company ProfilePremium

Icon PLC

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
Icon PLC - Healthcare showcase

Year Founded & Workforce

1990

38,000 Employees

Industry

Healthcare

Services

Infectious DiseaseOncologyCardiovascularFunctional Service ProvisionClinical Trial Management
I

Icon PLC Employee Contacts

135 verified contactsNames, job titles, seniority and locations

View Employee Contacts

Icon PLC Overview

Company Headquarters: Dublin, Ireland

Founded: 1990

Workforce: ~38,000

Company Working: Icon plc offers a wide range of clinical development, consulting, and commercialization services across 46 countries. It provides a wide range of services, including clinical research services, commercial positioning, functional services provision, laboratories, medical imaging, real-world intelligence, and site & patient solutions. The organization has extensive experience in diverse therapeutic areas such as cardiovascular, cell, and gene therapies, central nervous system, endocrine and metabolic disorders, infectious diseases, internal medicine and immunology, oncology, and pediatrics. Moreover, it operates in markets and industry verticals such as biosimilar, biotech, government & public health solutions, and pharmaceuticals and has operational facilities across 147 locations.

Strategy

Icon plc is highly focused on innovating new technologies to enhance efficiency and productivity. It is involved in developing solutions and services relevant to patient needs. Its therapeutic experts are dedicated to regular industry publications to help develop new solutions and services. Moreover, the organization aims to strengthen the operation, function, and therapeutic approaches to offer customized services to the customers. The company is increasing investment in R&D projects to improve major FSP functions such as clinical monitoring and statistical programming.

Company Snapshot

$2,365M

Revenue

38,000

Employees

1990

Founded

Dublin, Ireland

Headquarters

SWOT Analysis

Strengths

  • Global presence
  • Wide range of products
  • Strong operational capabilities
  • Customer-focused innovation and product development
  • Robust strategic development program to enhance the drug development process

Weaknesses

  • Major revenue dependence on the US and Ireland market
  • Limited presence in the MEA

Opportunities

  • Expanding in developing economies
  • Growing demand for outsourcing in pharmaceutical testing
  • Scope for adopting business strategies such as product development and collaboration with local players

Threats

  • Stringent government regulations
  • High completion among the major players
  • Fluctuation in operating expenses

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • Icon PLC
    • Infectious Disease
    • Oncology
    • Cardiovascular
    • Clinical Laboratory Test Systems, Reagents and Instrumentation
    • Functional Service Provision
    • Clinical Trial Management
    • Regulatory Consulting and Submissions
    • Data Management and Biostatistics
    • Patient Recruitment and Retention
    • Medical Imaging Services
    • Central Laboratory Services
    • Health Economics and Outcomes Research (HEOR)
    • Real-World Evidence Generation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales rose from USD 2,365 Mn in 2016 to USD 2,595.8 Mn in 2018.
Icon PLC — By Business Segment
Series (USD Mn)201620172018
Sales2,3652,402.32,595.8

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.